Expression of p53 as predictor for the development of esophageal cancer in achalasia patients

Diseases of the Esophagus

Volumn 23, Issue 6, 2010, Pages 506-511

  Leeuwenburgh, I ^a   Gerrits, M M ^a   Capello, A ^a   van den Bogert, B ^a   van Dekken, H ^a   Steyerberg, E W ^a   Siersema, P D ^a   Kuipers, E J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Achalasia; Esophageal cancer; Immunohistochemistry; P53; Surveillance

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; BALLOON DILATATION; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LONGITUDINAL STUDIES; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77955971212     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01040.x     Document Type: Article

References (27)

1. Richter J E. Oesophageal motility disorders. Lancet 2001, 358:823-8.
2. Loviscek L F, Cenoz M C, Badaloni A E, Agarinakazato O. Early cancer in achalasia. Dis Esophagus 1998, 11:239-47.
3. Lehman M B, Clark S B, Ormsby A H, Rice T W, Richter J E, Goldblum J R. Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia. Am J Surg Pathol 2001, 25:1413-8.
4. Leeuwenburgh I, Van Dekken H, Scholten P. Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther 2006, 23:1197-203.
5. Reynolds J C, Parkman H P. Achalasia. Gastroenterol Clin North Am 1989, 18:223-55.
6. Guo J P, Gilman P B, Thomas R M, Fisher R S, Parkman H P. Barrett's esophagus and achalasia. J Clin Gastroenterol 2002, 34:439-43.
7. Agha F P, Keren D F. Barrett's esophagus complicating achalasia after esophagomyotomy. A clinical, radiologic, and pathologic study of 70 patients with achalasia and related motor disorders. J Clin Gastroenterol 1987, 9:232-7.
8. Scholten P, Leeuwenburgh I, Vaessen R. Barrett's esophagus after Pneumo-dilatation for achalasia. Gastroenterology 2004, 126:A-635.
9. Carter R, Brewer L A. Achalasia and esophageal carcinoma. Studies in early diagnosis for improved surgical management. Am J Surg 1975, 130:114-20.
10. Lortat-Jacob J L, Richard C A, Fekete F, Testart J. Cardiospasm and esophageal carcinoma: report of 24 cases. Surg 1969, 66:969-75.
11. Just-Viera J O, Morris J D, Haight C. Achalasia and esophageal carcinoma. Ann Thorac Surg 1967, 3:526-38.
12. Wychulis A R, Woolam G L, Andersen H A, Ellis F H. Achalasia and carcinoma of the esophagus. JAMA 1971, 215:1638-41.
13. Chuong J J, DuBovik S, McCallum R W. Achalasia as a risk factor for esophageal carcinoma. A reappraisal. Dig Dis Sci 1984, 29:1105-8.
14. Meijssen M A, Tilanus H W, van Blankenstein M, Hop W C, Ong G L. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut 1992, 33:155-8.
15. Brucher B L, Stein H J, Bartels H, Feussner H, Siewert J R. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 2001, 25:745-9.
16. Streitz J M, Ellis F H, Gibb S P, Heatley G M. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995, 59:1604-9.
17. Reid B J. p53 and neoplastic progression in Barrett's esophagus. Am J Gastroenterol 2001, 96:1321-3.
18. Kerkhof M, Steyerberg E W, Kusters J G. Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer Biomark 2008, 4:1-10.
19. Ribeiro U, Posner M C, Safatle-Ribeiro A V, Reynolds J C. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg 1996, 83:1174-85.
20. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000, 182:311-22.
21. Levine A J, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature 1991, 351:453-6.
22. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003, 116:4077-85.
23. Merola E, Claudio P P, Giordano A. p53 and the malignant progression of Barrett's esophagus. J Cell Physiol 2006, 206:574-7.
24. Hinds P W, Finlay C A, Quartin R S. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the 'hot spot' mutant phenotypes. Cell Growth Differ 1990, 1:571-80.
25. Ireland A P, Clark G W, DeMeester T R. Barrett's esophagus. The significance of p53 in clinical practice. Ann Surg 1997, 225:17-30.
26. Keswani R N, Noffsinger A, Waxman I, Bissonnette M. Clinical use of p53 in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2006, 15:1243-9.
27. Hamelin R, Zucman J, Melot T, Delattre O, Thomas G. p53 mutations in human tumors with chimeric EWS/FLI-1 genes. Int J Cancer 1994, 57:336-40.